| scholarly article | Q13442814 |
| P50 | author | Baha Sibai | Q100559638 |
| P2093 | author name string | Wei Wang | |
| Yang Xia | |||
| Chen Liu | |||
| Patrick S Daugherty | |||
| Rodney E Kellems | |||
| Sean C Blackwell | |||
| Nicholas F Parchim | |||
| Renna Luo | |||
| Serra E Elliott | |||
| Takayuki Iriyama | |||
| P2860 | cites work | LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 |
| Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase | Q24548047 | ||
| LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer | Q24564377 | ||
| Cytokines as key players in the pathophysiology of preeclampsia | Q26830707 | ||
| Clinical practice. Celiac disease | Q28281691 | ||
| Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension | Q28575913 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification | Q33737470 | ||
| Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia | Q33740993 | ||
| Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. | Q34702420 | ||
| Coeliac disease: dissecting a complex inflammatory disorder | Q34810240 | ||
| Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 | ||
| Implementation of the third universal definition of myocardial infarction after coronary artery bypass grafting: a survey study in Western Europe | Q35088124 | ||
| Transglutaminase 2: a molecular Swiss army knife | Q35693361 | ||
| Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation | Q35697155 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity | Q35800493 | ||
| Post-translational modifications of self antigens: implications for autoimmunity | Q35931556 | ||
| Transglutaminase 2 inhibitors and their therapeutic role in disease states | Q35989247 | ||
| Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
| Is preeclampsia an autoimmune disease? | Q36050775 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders | Q36190939 | ||
| Inflammation and pre-eclampsia | Q36530771 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. | Q37543851 | ||
| Post-translational modifications, subcellular relocation and release in apoptotic microparticles: apoptosis turns nuclear proteins into autoantigens | Q37694076 | ||
| Characterization of antibody specificities associated with preeclampsia | Q37699015 | ||
| Autoantigenesis: the evolution of protein modifications in autoimmune disease | Q37972473 | ||
| Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. | Q38116097 | ||
| Immune response to chemically modified proteome | Q38174560 | ||
| The clinical significance of posttranslational modification of autoantigens | Q38212757 | ||
| TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells | Q38339721 | ||
| Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy | Q39697142 | ||
| Agonist-like activity of anti-peptide antibodies directed against an autoimmune epitope on the heart muscarinic acetylcholine receptor | Q41663241 | ||
| High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. | Q42462128 | ||
| Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine | Q43873037 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| Therapeutic effects of cystamine in a murine model of Huntington's disease. | Q44185981 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes | Q44657870 | ||
| Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia | Q44981840 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation | Q45077697 | ||
| Anti-peptide antibodies against an autoimmune epitope on human muscarinic receptor mimic functional autoantibodies against the same epitope in patients with idiopathic dilated cardiomyopathy | Q46167406 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Validation of volume-pressure recording tail-cuff blood pressure measurements | Q47304414 | ||
| Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease | Q47982815 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. | Q52900457 | ||
| Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? | Q52928690 | ||
| A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. | Q53090354 | ||
| A role for tissue transglutaminase in stabilization of membrane-cytoskeletal particles shed from the human placenta. | Q53541406 | ||
| Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. | Q54782424 | ||
| Trophoblast deportation in pre-eclamptic pregnancy | Q67780828 | ||
| Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy | Q69324044 | ||
| Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension | Q71662795 | ||
| Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma HepG2 cells | Q72214769 | ||
| Alpha 1-adrenergic receptor antibodies in patients with primary hypertension | Q73089177 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| The spontaneous reversal of pre-eclampsia associated with parvovirus-induced hydrops and the placental theory of pre-eclampsia: a case report | Q79356221 | ||
| Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients | Q82213207 | ||
| P433 | issue | 12 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| autoantibody | Q785022 | ||
| P577 | publication date | 2015-12-16 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia | |
| P478 | volume | 4 |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q107324240 | Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 |
| Q91842370 | Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia |
| Q39198610 | Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase |
| Q55259961 | Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension. |
| Q37240779 | Transglutaminase is a Critical Link Between Inflammation and Hypertension |
Search more.